- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00002064
Toxoplasmic Encephalitis in Patients With AIDS. Treatment and Prevention of Relapse
June 23, 2005 updated by: Palo Alto Medical Foundation
To compare pyrimethamine and intravenous (IV) clindamycin vs. pyrimethamine and sulfonamides in the treatment of AIDS patients with central nervous system (CNS) Toxoplasma gondii.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Palo Alto, California, United States, 94301
- Palo Alto Med Foundation
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Exclusion Criteria
Co-existing Condition:
Patients with the following conditions are excluded:
- Opportunistic infection (Pneumocystis carinii pneumonia (PCP), cryptococcal meningitis) or other conditions (brain abscess) which would make treatment results difficult to interpret due to concurrent infection, disease, or therapy.
Patients with other opportunistic infections or brain diseases are excluded.
Patients with AIDS and cerebral toxoplasmosis.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
November 2, 1999
First Submitted That Met QC Criteria
August 30, 2001
First Posted (Estimate)
August 31, 2001
Study Record Updates
Last Update Posted (Estimate)
June 24, 2005
Last Update Submitted That Met QC Criteria
June 23, 2005
Last Verified
June 1, 1989
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Infections
- Central Nervous System Infections
- Parasitic Diseases
- Coccidiosis
- Protozoan Infections
- Suppuration
- Central Nervous System Parasitic Infections
- Abscess
- Brain Abscess
- Central Nervous System Protozoal Infections
- Encephalitis
- Toxoplasmosis
- Toxoplasmosis, Cerebral
- Molecular Mechanisms of Pharmacological Action
- Anti-Infective Agents
- Enzyme Inhibitors
- Anti-Bacterial Agents
- Protein Synthesis Inhibitors
- Antiprotozoal Agents
- Antiparasitic Agents
- Antimalarials
- Folic Acid Antagonists
- Clindamycin
- Clindamycin palmitate
- Clindamycin phosphate
- Pyrimethamine
Other Study ID Numbers
- 021A
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Infections
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
University of California, San DiegoUniversity of California, Los Angeles; University of Southern California; California... and other collaboratorsCompleted
-
Gérond'ifRecruiting
-
University of California, DavisCompleted
-
University of California, San DiegoNational Center for Complementary and Integrative Health (NCCIH)CompletedHIV PositiveUnited States
-
University of ChicagoUniversity of Athens; National Development and Research Institutes, Inc.Completed
-
HIV Prevention Trials NetworkNational Institute on Drug Abuse (NIDA); National Institute of Allergy and...CompletedHIV PositiveIndonesia, Ukraine, Vietnam
-
University of ZimbabweCompleted
-
Florida International UniversityCompleted
-
Boston Children's HospitalNational Institute on Minority Health and Health Disparities (NIMHD)Completed
Clinical Trials on Pyrimethamine
-
London School of Hygiene and Tropical MedicineMinistry of Health, GhanaCompleted
-
University of MelbourneUniversity of Barcelona; Papua New Guinea Institute of Medical Research; The... and other collaboratorsCompletedSexually Transmitted Infections | Malaria in Pregnancy | AnaemiaPapua New Guinea
-
Tampere UniversityAcademy of Finland; Foundation for Paediatric Research, FinlandActive, not recruitingSexually Transmitted Diseases | Pregnancy | Preterm Birth | MalariaMalawi
-
London School of Hygiene and Tropical MedicineCheikh Anta Diop University, SenegalCompleted
-
Walter Reed Army Institute of Research (WRAIR)CompletedMalaria, Falciparum | Malaria, VivaxPeru
-
Emzor Pharmaceutical Industries LimitedNot yet recruiting
-
Centers for Disease Control and PreventionKenya Medical Research Institute; Kenya Ministry of HealthCompleted
-
University of Cape TownWorld Health Organization; Medical Research Council, South AfricaCompleted
-
London School of Hygiene and Tropical MedicineMalaria Research and Training Center, Bamako, Mali; Institut de Recherche en...CompletedMalaria | Respiratory InfectionsBurkina Faso, Mali
-
London School of Hygiene and Tropical MedicineTerminated